Literature DB >> 15456553

Symptoms of depression and anxiety in post-myocardial infarction patients.

Muhammad Saleem Akhtar1, Saad Bashir Malik, Masha Maqbool Ahmed.   

Abstract

OBJECTIVE: To assess the frequency of symptoms of depression and/or anxiety following acute myocardial infarction (AMI) and to analyse their association with demographic variables.
DESIGN: A cross-sectional analytical, non-interventional hospital based study. PLACE AND DURATION OF STUDY: The study was carried out at Punjab Institute of Cardiology (PIC), Lahore, from January 2000 to January 2001. PATIENTS AND METHODS: A total number of 100 inpatients suffering from AMI were studied. After a careful selection of the subjects the Urdu version of Hospital Anxiety and Depression Scale (HADS) was administered to each patient during the period of 5-7 days following AMI to assess symptoms of depression and anxiety. A semi-structured clinical interview was also conducted which included demographic information, psychiatric history and other variables. Results were analyzed by using Statistical Package for Social Sciences (SPSS version 8.0).
RESULTS: Out of 100 subjects, 80 (80%) were males and 20 (20%) were females. Their ages ranged from 30-60 years (mean age, 50.92+/-8.53). Overall, symptoms of anxiety and/or depression were found in 50 (50%) patients. More specifically, symptoms of depression were found in 14%, anxiety symptoms in 18% and mixed symptoms (anxiety and depression) in 18% of the patients. Results revealed that patients above 45 years of age (i.e. 46-60 years) were more likely to experience symptoms of depression and/ or anxiety following AMI. A significant association was also found between female sex (p <0.02), lower socioeconomic status (p <0.05) and symptoms of depression and/ or anxiety in these patients. However, no significant association was found in relation to educational status, marital status and origin (urban/rural).
CONCLUSION: The high proportion of patients with AMI found to be suffering from symptoms of depression and/ or anxiety one week after AMI highlights the essential need to assess these symptoms in all such patients during the post-MI period as they merit appropriate treatment along with the other complications of AMI.

Entities:  

Mesh:

Year:  2004        PMID: 15456553     DOI: 10.2004/JCPSP.615618

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

Review 1.  AAFP guideline for the detection and management of post-myocardial infarction depression.

Authors: 
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

Review 2.  Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis.

Authors:  Yajun Lian; Jingsha Xiang; Xiaoyan Wang; Atipatsa C Kaminga; Wenhang Chen; Zhiwei Lai; Wenjie Dai; Jianzhou Yang
Journal:  Psychiatr Q       Date:  2021-05-19

3.  Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome.

Authors:  Prasanta Kumar Mohapatra; Nilamadhab Kar; Gopal Chandra Kar; Mrutyunjaya Behera
Journal:  Clin Pract Epidemiol Ment Health       Date:  2005-12-09

4.  Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction.

Authors:  Jinpeng Wang; Ping Li; Tian Qin; Dongjie Sun; Xin Zhao; Beilin Zhang
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

5.  Psychological Profile in Coronary Artery By-Pass Graft Patients vs. Valve Replacement Patients Entering Cardiac Rehabilitation after Surgery.

Authors:  Maddalena Modica; Paolo Castiglioni; Anna Minotti; Andrea Faini; Vittorio Racca; Maurizio Ferratini
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

6.  Efficacy of CPET Combined with Systematic Education of Cardiac Rehabilitation After PCI: A Real-World Evaluation in ACS Patients.

Authors:  Quan-Yu Zhang; Qiang Hu; Yi Li; Yi Sun; Jing-Fei He; Miao-Han Qiu; Jian Zhang; Yan-Chun Liang; Ya-Ling Han
Journal:  Adv Ther       Date:  2021-08-05       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.